Business Context and Reporting Period
This Form 8-K is filed by Bond Laboratories, Inc. (referred to in metadata as FITLIFE BRANDS, INC.) for the reporting date of September 7, 2011. The filing addresses preliminary sales results for August 2011 and a change in the Board of Directors.
Key Financial Metrics
- Preliminary Sales (August 2011): Approximately $1.15 million.
- Prior Period Sales (August 2010): Approximately $600,000.
- Profit, Cash Flow, Margins, Debt, and Liquidity: The filing text does not provide clear values for these metrics.
Material Changes
The Company reported a significant increase in preliminary sales for August 2011 compared to the same period in the prior year, rising from approximately $600,000 to $1.15 million. Additionally, Elorian Landers resigned as a member of the Board of Directors effective September 7, 2011, with no reported disagreement regarding company operations or policies.
Guidance, Outlook, and Risks
The sales figures disclosed are preliminary only. The Company intends to release official results of operations for the quarter ended September 30, 2011, in its upcoming Quarterly Report on Form 10-Q. No specific forward-looking guidance, risk factors, or contingencies were detailed in this specific filing beyond the preliminary nature of the sales data.
Investor Verification Checklist
- Verify the final audited sales figures for August 2011 and the quarter ended September 30, 2011, in the upcoming Form 10-Q.
- Confirm the appointment of a replacement director to fill the vacancy left by Elorian Landers.
- Review the full financial statements in the Form 10-Q to assess profitability, cash flow, and liquidity, as these are not included in this 8-K.